Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids

Steroids

Volumn 66, Issue 7, 2001, Pages 597-604

  Jaffuel, Dany ^a   Roumestan, Caroline ^a   Balaguer, Patrick ^b   Henriquet, Corinne ^a   Gougat, Claire ^a   Bousquet, Jean ^a   Demoly, Pascal ^a   Mathieu, Marc ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Gene expression; Glucocorticoid; Hyperglycemia; Steroid; trans Activation; Tyrosine aminotransferase

Indexed keywords

BETA GALACTOSIDASE; BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; LUCIFERASE; METHYLPREDNISOLONE; PREDNISOLONE; TRIAMCINOLONE ACETONIDE; TYROSINE AMINOTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG POTENCY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; GLUCONEOGENESIS; HELA CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; RAT; REPORTER GENE;

DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; GLUCOCORTICOIDS; HUMANS; INHIBITORY CONCENTRATION 50; LUCIFERASES; REPRODUCIBILITY OF RESULTS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TYROSINE TRANSAMINASE;

EID: 0035400940     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00235-X     Document Type: Article

References (40)

1. Nuclear factor-κ B repression in antiinflammation and immunosuppression by glucocorticoids
2. Structure of the gene for human β2-adrenergic receptor; expression and promoter characterization
3. Protective effects of a glucocorticoid on downregulation of pulmonary β2-adrenergic receptors in vivo
4. Immunosuppression by glucocorticoids; inhibition of NF-κ B activity through induction of I kappa B synthesis
5. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
6. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis
7. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation
8. I kappaB α-independent downregulation of NF-kappaB activity by glucocorticoid receptor
9. β-adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells
10. Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter
11. Glucocorticoid induction of epithelial sodium channel expression in lung and renal epithelia occurs via trans-activation of a hormone response element in the 5′-flanking region of the human epithelial sodium channel α subunit gene
12. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene
13. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids
14. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells
15. Identification of a gene that causes primary open angle glaucoma
16. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice
17. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring
18. Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins
19. S26 ribosomal protein RNA; an invariant control for gene regulation experiments in eucaryotic cells and tissues
20. A new cellular model of response to estrogens; a bioluminescent test to characterize (anti)estrogen molecules
21. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery
22. The glucocorticoid receptor gene as a candidate for gene therapy in asthma
23. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
24. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity
25. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids
26. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids
27. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids
28. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration
29. Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene
30. Phenylalanine-780 near the C-terminus of the mouse glucocorticoid receptor is important for ligand binding affinity and specificity
31. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription
32. Cortisol increases transfection efficiency of cells
33. Engineered cell lines as a tool for monitoring biological activity of hormone analogs
34. Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration
35. Compative studies of effects and side effects of hydrocortisone, prednisone, triamcinoline and dexamethasone
36. Effect of high-dose i.m. triamcinolone in older adults with severe, chronic asthma
37. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids